Daily Cancer News

OMNI Health Media is a leading online provider of Daily Cancer News. OMNI’s Daily Cancer News provides summaries of new treatment strategies as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating cancer therapies and supportive care strategies, to better educate patients and their caregivers, ensuring timely access to the best cancer care available.

CancerConnect Cancer Commuity & Discussions

Share


Latest Cancer News


Novel Antibody Improves Survival in Advanced Stomach Cancer (June 28, 2016)

The novel agent, IMAB362, which stimulates the immune system to attack a certain protein expressed by many stomach cancer cells, has demonstrated a significant improvement in survival compared to standard... Continue Reading

Stent Placement Reduces Need for Stoma in Some Colorectal Cancers (June 27, 2016)

The placement of a stent as initial emergency treatment for colon obstruction reduces the need for a stoma without adversely affecting outcomes for patients with potentially curable colorectal cancer.... Continue Reading

About PCROWD, Dana-Farber’s tissue-banking study for patients with Myeloproliferative Neoplasms, Smoldering Multiple Myeloma, Smoldering Waldenstrom’s Macroglobulemia, and Early Myelodysplastic Syndromes (June 27, 2016)

PCROWD (“Precursor CROWDsourcing”) – a tissue banking and clinical information study and repository – is an indispensable component of the blood cancer research pipeline. The main objective... Continue Reading

CancerConnect Launches Online Community for Patients Diagnosed with Histiocytosis (June 24, 2016)

Sun Valley ID & Austin TX– OMNI Health Media (OMNI) announces the launch of a new online community on CancerConnect for adults affected by histiocytosis. This community will provide patients and... Continue Reading

Blincyto® Improves Survival in Type of Acute Lymphoblastic Leukemia (June 23, 2016)

The immunotherapeutic agent, Blincyto (blinatumomab), improves survival compared to standard therapy among patients with B-cell precursor, Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia... Continue Reading

Have Questions about Cancer Nutrition? Read This (June 22, 2016)

CancerConnect and the Cancer Center at Beth Israel Deaconess Medical Center Present: Ask the Expert with Oncology Nutrition Specialists CancerConnect in collaboration with the Cancer Center at Beth Israel... Continue Reading

Directly Involving Patients Drives Participation in Metastatic Breast Cancer Study (June 22, 2016)

A clinical study to accelerate research in metastatic breast cancer has rapidly enrolled participants through direct collaboration with patients. These results were recently presented at the 2016 annual... Continue Reading

Jakafi Superior to Standard Treatment in Polycythemia Vera (June 21, 2016)

Treatment with Jakafi® (ruxolitinib) was superior to best available treatment among patients with inadequately controlled polycythemia vera (PV). These results were recently presented at the 21st Congress... Continue Reading

CAR Therapy Effective in Advanced Lymphoma (June 20, 2016)

According to results of several presentations at the 2016 annual meeting of the American Society of Clinical Oncology (ASCO), chimeric antigen receptor (CAR) therapies appear to have significant anti-cancer... Continue Reading

Innovative Colorectal Cancer Screening Methods for Remote Areas (June 16, 2016)

Colorectal cancer is the second-leading cause of cancer-related death in the United States, despite the fact that more than half of these deaths are avoidable with regular screenings. In fact, with screening,... Continue Reading

Promising Activity of Pembrolizumab in Merkel Cell Carcinoma (June 14, 2016)

Treatment of 26 patients with advanced previously untreated Merkel cell carcinoma with Keytruda® (pembrolizumab) every three weeks resulted in an overall response rate of 56% suggesting this novel therapy... Continue Reading

FDA Approves New Imaging Agent for Detection of Recurrent Prostate Cancer (June 13, 2016)

The United States Food and Drug Administration (FDA) has approved Axumin (fluciclovine F 18), an radioactive agent, to be used in positron emission tomography (PET) imaging for the detection of recurrent... Continue Reading

Compliance with Radiation Schedules Improves Survival in Head and Neck Cancer (June 9, 2016)

Patients with head and neck cancer who comply with their scheduled radiation treatments have significantly improved outcomes compared to those who miss 2 or more of their appointments within the prescribed... Continue Reading

Gazyva® Showed Superior Progression-Free Survival Compared to Rituxan® in Follicular Lymphoma (June 8, 2016)

A study in people with previously untreated follicular lymphoma, the most common type of indolent (slow-growing) non-Hodgkin’s lymphoma (iNHL) suggests that  Gazyva® (obinutuzumab) plus chemotherapy... Continue Reading

Tecentriq® Approved for Bladder Cancer (June 8, 2016)

The United States Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab) for the treatment of bladder cancer. Atezolizumab is an immunotherapy agent referred to as a PD-1/PD-L1 inhibitor,... Continue Reading

Ask the Cancer Nutrition Expert Q&A Now Available! (June 8, 2016)

CancerConnect and the Cancer Center at Beth Israel Deaconess Medical Center Present: Ask the Expert with Oncology Nutrition Specialists   CancerConnect in collaboration with the Cancer Center at Beth... Continue Reading

Tecentriq® Effective as Initial Therapy in Advanced Bladder Cancer (June 8, 2016)

The immunotherapy agent Tecentriq® (atezolizumab) provides anti-cancer activity when used as initial therapy among patients with advanced bladder cancer who are not able to tolerate standard therapy.... Continue Reading

Long-Lasting Responses Achieved with Keytruda® in Advanced Head and Neck Cancer (June 8, 2016)

Treatment with the immune-stimulating agent, Keytruda® (pembrolizumab), provides impressive long-term outcomes for some patients with metastatic or recurrent head and neck cancer. These results were recently... Continue Reading

More Cancer News

CancerConnect Cancer Commuity & Discussions


Cancer Types



Headline News by Cancer Type


Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS